WHAT’S NEW(What does this article add)?
The aim of this study was to use a L-Carnitine supplement in critically
ill patients. Since in previous studies in cardiovascular patients this
supplement had reduced inflammation, we decided to use this supplement
due to high inflammation in critically ill patients, which in our study
was also Inflammatory factors were significantly reduced and mortality
was reduced for 28 days mortality. This study is a starting point for
future plans that are currently reviewing and conducting an L-carnitine
supplementation plan in Covid 19 patients to reduce infection and
inflammation in imam reza hospital.